New Jersey Organ And Tissue Sharing Network Inc

New Jersey Organ And Tissue Sharing Network Inc: Strong Program Spending, but Transparency Lacking

EIN: 222490603 · New Providnce, NJ · NTEE: E650 · Updated: 2026-04-04

$59.6MRevenue
$65.1MAssets
85/100Mission Score (Excellent)
E650

Resolve This Donation Decision

Should someone trust, compare, or avoid New Jersey Organ And Tissue Sharing Network Inc?

This page is being rebuilt as a decision workflow: verify the public record, understand where money goes, compare better nearby or category peers, then save the evidence into a report or watchlist when the decision matters.

Source and Resolution Links

Finish the Investigation Outside Our Dataset

When the answer lives with the IRS, ProPublica, Candid, Charity Navigator, or the nonprofit itself, NonprofitSpending links out instead of trapping the user on a partial answer.

IRS tax-exempt lookup

Verify exemption status and deductibility directly with the IRS.

ProPublica 990 source

Open the raw filing record and filing PDFs outside NonprofitSpending.

Candid profile search

Look for GuideStar/Candid profile details, programs, leadership, and seals.

Charity Navigator search

Check whether another evaluator has ratings or impact context.

Workflow Engine

Queries We Should Resolve, Not Just Answer

Search Console demand points to task completion. Each workflow can run calculations, source checks, external lookups, comparisons, and report/export capture around this nonprofit.

Verify tax status Runnable

Triggered by: 501(c)(3), tax deductible, EIN

IRS status check plus source links

Find source filings Runnable

Triggered by: 990 PDF, annual report, filing record

13 stored filing years plus ProPublica source

Crunch money signals Runnable

Triggered by: program expense ratio, CEO salary, revenue, grants

89% program spend, health grade A

Compare alternatives Runnable

Triggered by: best charities, similar nonprofits, compare

4 peer options surfaced

Resolve leadership and board Runnable

Triggered by: executive team, trustees, officer pay

Use 990 compensation disclosures and external profile links.

Donation decision copilot Runnable

Triggered by: should I donate, give or compare, charity safety

Eligibility, money signals, sources, peer context, and next action.

Grantmaker due diligence Runnable

Triggered by: foundation review, grant risk, grantee capacity

Foundation-style packet across filings, finances, governance, and gaps.

Impact evidence finder Runnable

Triggered by: outcomes, annual report, cost effectiveness

Separate actual impact evidence from raw 990 financial cleanliness.

Room for more funding Runnable

Triggered by: would my donation help, funding gap, marginal impact

Revenue trend, runway, surplus/deficit, and source follow-ups.

Operator transparency diagnostic Runnable

Triggered by: how does my nonprofit look to donors

Profile, filing, impact, and transparency improvements to earn trust.

New Jersey Organ And Tissue Sharing Network Inc Financial Summary
MetricValue
Total Revenue$59.6M
Total Expenses$48.6M
Program Spending89%
Net Assets$47.9M
Transparency Score85/100

Search Intent Cockpit

New Jersey Organ And Tissue Sharing Network Inc Form 990, Revenue, CEO Pay, and IRS Filing Signals

New Jersey Organ And Tissue Sharing Network Inc is surfaced here as a decision-ready nonprofit financial profile, not just a charity listing. The page consolidates IRS Form 990 revenue, expenses, assets, tax-exempt classification, executive compensation, mission score, red flags, and year-by-year filing history so donors, researchers, journalists, and grant teams can answer the common search questions around New Jersey Organ And Tissue Sharing Network Inc in one place.

Form 990 Filing Summary

13 filing years are available, with latest revenue of $54.2M and expenses of $48.6M.

Revenue and Expenses

New Jersey Organ And Tissue Sharing Network Inc reported $54.2M in revenue and $48.6M in expenses, a surplus of $5.6M.

Executive Compensation

Officer, director, trustee, and key employee pay is reviewed from IRS 990 compensation disclosures when present.

Charity Score and Red Flags

85/100 mission score, 2 red flags, and 3 strengths are shown from structured and AI review.

Is New Jersey Organ And Tissue Sharing Network Inc Legit?

Some Concerns

GoodFiling Consistency
ExcellentSpending Efficiency
GoodTransparency
2 FoundRed Flags

Assessment based on IRS 990 filings, spending patterns, and AI analysis. Not a guarantee of legitimacy. Full charity check →

IRS 990 Data Cockpit

Where the Money Comes From and Where It Goes

PendingDonor/Grant Funding
89%Program Expense
$0Grants Paid
13Stored Filing Years

Revenue Source Mix

Revenue-source line items are not available on the stored filing yet. Future ingestion now preserves contribution, program-revenue, and investment-income fields when ProPublica provides them.

Expense Deployment

New Jersey Organ And Tissue Sharing Network Inc Expense Deployment
Program services$43.3M (89%)

Across stored filings, New Jersey Organ And Tissue Sharing Network Inc shows contribution history pending. Next enrichment targets: revenue-source fields, IRS BMF classification.

Decision Cockpit

One-Stop Donor, Research, and Peer Context Hub

New Jersey Organ And Tissue Sharing Network Inc Donor Decision Matrix
Decision LensSignalWhat to Inspect Next
LegitimacySome ConcernsGood filing record; 2 red flags identified
Mission spend89% to programsExcellent
Financial durabilityGrade A13 stored filing years
Peer contextCompare with Dance For The Cure IncNew Jersey and Health context

Trust Check

Review legitimacy, deductibility, red flags, and filing consistency.

Open charity check →

Peer Benchmark

Compare against real state and category peers.

Compare with Dance For The Cure Inc →
All New Jersey nonprofits
All Health

Local and Sector Spokes

Move into this nonprofit's local market, category, and sector maps.

New Providnce, NJ nonprofits
Health in New Jersey
Health in New Jersey

Follow the Money

Jump into spending, compensation, rankings, and filing-year evidence.

State spending analysis
State compensation analysis
Health spending
Best Health charities in New Jersey
Relevant rankings

Donation Decision Flow

From Trust Check to Better Alternatives

1

Verify

Some Concerns. Check deductibility, filings, and red flags.

2

Understand money

89% of spending goes to programs.

3

Compare

Benchmark against Dance For The Cure Inc.

4

Decide

Build a shortlist, compare alternatives, and review the latest filing before giving.

Alternative Shopping

Similar Nonprofits Donors Should Compare

Browse the full Health peer market in New Jersey →

Next Best Actions

Keep the Investigation Moving

Verify legitimacy

Open the focused charity-check flow before donating.

Compare a peer

Benchmark against Dance For The Cure Inc.

Find best peers

See best Health charities in New Jersey.

Inspect local compensation

See whether pay levels look unusual in this state.

Research Workflow

Turn this Form 990 profile into a donor-ready report

Request a concise report for New Jersey Organ And Tissue Sharing Network Inc with revenue, expenses, executive compensation, red flags, peer context, and IRS source links. You can also request CSV exports or watchlist updates for future filings.

Get spending reportDonor-ready PDF summary.
Request CSV exportFiling-year data for research.
Watch this nonprofitUpdates when public data changes.

Early access request only. Reports and exports are informational and based on public IRS records, not financial or legal advice.

New Jersey Organ And Tissue Sharing Network Inc directs 89% of its spending to programs. This exceeds the industry benchmark of 65%, indicating strong mission focus.

About New Jersey Organ And Tissue Sharing Network Inc

New Jersey Organ And Tissue Sharing Network Inc (EIN: 222490603) is a nonprofit organization based in New Providnce, NJ, classified under NTEE code E650. The organization reported total revenue of $59.6M and total assets of $65.1M according to its most recent IRS 990 filing. This transparency report provides an AI-powered analysis of New Jersey Organ And Tissue Sharing Network Inc's financial health, spending patterns, executive compensation, and overall mission effectiveness based on publicly available IRS data.

Organization Overview

40Years Operating
MajorSize Classification
13Years of Filings
MixedRevenue Trajectory

New Jersey Organ And Tissue Sharing Network Inc is a major nonprofit that has been operating for 40 years, with 13 years of IRS 990 filings on record (2011–2023). Revenue has grown at a compound annual rate of 4.1%.

Key Financial Metrics (2023)

From the most recent IRS 990 filing on record:

Total Revenue$54.2M
Total Expenses$48.6M
Surplus / Deficit+$5.6M
Total Assets$62.0M
Total Liabilities$14.1M
Net Assets$47.9M
Operating Margin10.3%
Debt-to-Asset Ratio22.8%
Months of Reserves15.3 months

Financial Health Grade: A

In 2023, New Jersey Organ And Tissue Sharing Network Inc reported a surplus of $5.6M with revenue exceeding expenses, holds 15.3 months of operating reserves (strong position), has a debt-to-asset ratio of 22.8% (moderate leverage).

Financial Trends

Over 13 years of filings (2011–2023), New Jersey Organ And Tissue Sharing Network Inc's revenue has grown at a compound annual growth rate (CAGR) of 4.1%.

YearRevenue ChangeExpense ChangeAsset Change
2023-13.0%-14.3%+9.8%
2022+2.6%+0.8%+17.6%
2021+23.1%+25.2%+6.9%
2020-3.9%-2.7%+16.0%
2019+23.6%+15.2%+25.0%

IRS Tax-Exempt Classification

IRS Classification Codes1000
IRS Ruling Date1986

Classification data from ProPublica Nonprofit Explorer. Additional BMF data may be available after enrichment.

AI Transparency Report

New Jersey Organ And Tissue Sharing Network Inc is a health care nonprofit based in New Providnce, New Jersey, with reported revenue of $59.6M and assets of $65.1M. Our AI analysis assigns a Mission Score of 85/100 (Excellent). Approximately 89% of spending goes to programs, 5% to administration, and 6% to fundraising. Executive compensation cannot be assessed as specific compensation figures for executives are not provided in the available financial data. Revenue has grown +61% across 13 filing periods.

Mission Effectiveness Score

NonprofitSpending's AI analysis rates New Jersey Organ And Tissue Sharing Network Inc with a Mission Score of 85 out of 100 (Excellent). This score reflects the organization's overall financial transparency, program spending efficiency, and governance indicators derived from IRS 990 public filings.

Spending Breakdown

  • admin: 5%
  • programs: 89%
  • fundraising: 6%

According to IRS 990 filings, New Jersey Organ And Tissue Sharing Network Inc allocates its expenses as follows: admin: 5%, programs: 89%, fundraising: 6%. With 89% directed toward programs, this reflects a strong commitment to its charitable mission.

Key Financial Metrics (2023)

From the most recent IRS 990 filing on record:

$54.2MTotal Revenue
$48.6MTotal Expenses
$62.0MTotal Assets
$14.1MTotal Liabilities
$47.9MNet Assets
  • The organization reported a surplus of $5.6M, with revenue exceeding expenses.
  • Debt-to-asset ratio: 22.8%.

Executive Compensation Analysis

Executive compensation cannot be assessed as specific compensation figures for executives are not provided in the available financial data.

Executive compensation data is sourced from IRS 990 filings, which require nonprofits to disclose the compensation of officers, directors, trustees, and key employees. NonprofitSpending analyzes this data relative to the organization's total revenue and sector benchmarks to assess whether executive pay is reasonable.

Red Flags

The following concerns were identified during AI analysis of New Jersey Organ And Tissue Sharing Network Inc's IRS 990 filings:

  • Lack of detailed executive compensation disclosure in the provided data.
  • Limited public transparency regarding specific program outcomes and impact metrics beyond general financial statements.

Strengths

The following positive indicators were identified for New Jersey Organ And Tissue Sharing Network Inc:

  • Consistently high percentage of expenses dedicated to programs (e.g., 89% in 2023 based on available data).
  • Significant revenue and asset base, indicating a stable and established organization.
  • Consistent growth in assets over the past several years, from $26,767,454 in 2017 to $61,996,298 in 2023.

Frequently Asked Questions about New Jersey Organ And Tissue Sharing Network Inc

Is New Jersey Organ And Tissue Sharing Network Inc a legitimate charity?

New Jersey Organ And Tissue Sharing Network Inc (EIN: 222490603) is a registered tax-exempt nonprofit based in New Jersey. Our AI analysis gives it a Mission Score of 85/100. It has 13 years of IRS 990 filings on record. Total revenue: $59.6M. 2 red flags identified. 3 strengths noted. Financial health grade: A.

How does New Jersey Organ And Tissue Sharing Network Inc spend its money?

New Jersey Organ And Tissue Sharing Network Inc directs 89% of its spending to programs and services. Fundraising costs 6%. This exceeds the 65% industry benchmark.

Are donations to New Jersey Organ And Tissue Sharing Network Inc tax-deductible?

New Jersey Organ And Tissue Sharing Network Inc is registered as a tax-exempt nonprofit (EIN: 222490603). Donations to most 501(c)(3) organizations are tax-deductible. Consult a tax professional for your specific situation.

What percentage of New Jersey Organ And Tissue Sharing Network Inc's spending goes to programs?

New Jersey Organ And Tissue Sharing Network Inc directs 89% to programs, 6% to fundraising. This exceeds the 65% industry benchmark for efficient nonprofits.

How does New Jersey Organ And Tissue Sharing Network Inc compare to similar nonprofits?

With a transparency score of 85/100 (Excellent), New Jersey Organ And Tissue Sharing Network Inc is above average for NTEE category E650 nonprofits. The score reflects financial transparency, program spending efficiency, and governance quality based on IRS 990 data.

Where is New Jersey Organ And Tissue Sharing Network Inc located?

New Jersey Organ And Tissue Sharing Network Inc is headquartered in New Providnce, New Jersey and files with the IRS under EIN 222490603. It is classified under NTEE code E650.

How many years of IRS 990 filings does New Jersey Organ And Tissue Sharing Network Inc have?

New Jersey Organ And Tissue Sharing Network Inc has 13 years of IRS 990 filings on record at NonprofitSpending. This extensive filing history provides a strong basis for evaluating long-term financial trends. The most recent filing shows $59.6M in total revenue.

What does New Jersey Organ And Tissue Sharing Network Inc do?

New Jersey Organ And Tissue Sharing Network Inc is a nonprofit organization in the Health Care sector, located in New Providnce, New Jersey. It is classified under NTEE code E650.

How much revenue does New Jersey Organ And Tissue Sharing Network Inc have?

New Jersey Organ And Tissue Sharing Network Inc reported total revenue of $59,609,072. Based on 13 IRS 990 filings on record.

What are New Jersey Organ And Tissue Sharing Network Inc's total assets?

New Jersey Organ And Tissue Sharing Network Inc holds total assets of $65,068,950 as reported in IRS 990 filings.

Where is New Jersey Organ And Tissue Sharing Network Inc located?

New Jersey Organ And Tissue Sharing Network Inc is based in New Providnce, New Jersey.

What is New Jersey Organ And Tissue Sharing Network Inc's EIN?

New Jersey Organ And Tissue Sharing Network Inc's Employer Identification Number (EIN) is 222490603. This is the unique tax ID assigned by the IRS for tax-exempt organizations.

What type of nonprofit is New Jersey Organ And Tissue Sharing Network Inc?

New Jersey Organ And Tissue Sharing Network Inc is classified under NTEE code E650 (Health Care).

Is New Jersey Organ And Tissue Sharing Network Inc a registered 501(c)(3)?

Yes, New Jersey Organ And Tissue Sharing Network Inc is recognized as a tax-exempt organization by the IRS. EIN: 222490603.

Does New Jersey Organ And Tissue Sharing Network Inc file IRS Form 990?

Yes, New Jersey Organ And Tissue Sharing Network Inc has 13 IRS Form 990 filings on record. The most recent covers tax period 202312.

What was New Jersey Organ And Tissue Sharing Network Inc's revenue in 2023?

In the 202312 filing period, New Jersey Organ And Tissue Sharing Network Inc reported total revenue of $54,219,381, total expenses of $48,617,885, and net assets of $61,996,298.

Is New Jersey Organ And Tissue Sharing Network Inc's revenue growing or declining?

New Jersey Organ And Tissue Sharing Network Inc's revenue is declining. Revenue went from $62,288,754 (202212) to $54,219,381 (202312), a -13.0% change. Based on 13 filings on record.

What is New Jersey Organ And Tissue Sharing Network Inc's most recent 990 filing?

The most recent IRS Form 990 filing for New Jersey Organ And Tissue Sharing Network Inc covers tax period 202312. It shows revenue of $54,219,381, expenses of $48,617,885, total assets of $61,996,298, and liabilities of $14,106,821.

How much does New Jersey Organ And Tissue Sharing Network Inc spend on programs vs administration?

Based on IRS 990 analysis, New Jersey Organ And Tissue Sharing Network Inc allocates approximately 89% of expenses to program services, 5% to administrative costs, and 6% to fundraising. This indicates strong program focus.

Is New Jersey Organ And Tissue Sharing Network Inc a trustworthy charity?

Based on AI analysis of IRS 990 data, New Jersey Organ And Tissue Sharing Network Inc appears trustworthy. Mission Score: 85/100 (Excellent). 2 red flags identified. 3 strengths noted.

What are the red flags for New Jersey Organ And Tissue Sharing Network Inc?

The following concerns were identified: Lack of detailed executive compensation disclosure in the provided data.. Limited public transparency regarding specific program outcomes and impact metrics beyond general financial statements.. These flags are based on automated analysis of IRS 990 public filings and should be verified independently.

What are New Jersey Organ And Tissue Sharing Network Inc's strengths?

Positive indicators for New Jersey Organ And Tissue Sharing Network Inc include: Consistently high percentage of expenses dedicated to programs (e.g., 89% in 2023 based on available data).. Significant revenue and asset base, indicating a stable and established organization.. Consistent growth in assets over the past several years, from $26,767,454 in 2017 to $61,996,298 in 2023.. These findings are derived from AI analysis of the organization's financial filings.

How does New Jersey Organ And Tissue Sharing Network Inc compensate executives?

Executive compensation cannot be assessed as specific compensation figures for executives are not provided in the available financial data. Executive compensation data is sourced from IRS 990 filings, which require disclosure of officer, director, and key employee pay.

Given the substantial revenue and assets, what specific initiatives or technologies are being invested in to further enhance organ and tissue sharing efficiency and reach within New Jersey?

The provided data does not detail specific program initiatives or technological investments. Further investigation into their annual reports or program descriptions would be needed to answer this.

How does the organization measure and report the success rates and impact of its organ and tissue sharing programs, particularly in terms of lives saved or improved?

The provided financial data does not include metrics on program success rates or impact. This information would typically be found in an annual impact report or program-specific documentation.

Filing History

IRS 990 filing history for New Jersey Organ And Tissue Sharing Network Inc showing financial trends over 13 years of public records:

Over 13 years of IRS 990 filings (2011–2023), New Jersey Organ And Tissue Sharing Network Inc's revenue has grown by 61.5%, moving from $33.6M to $54.2M. Total assets increased by 296.9% over the same period, from $15.6M to $62.0M. Total functional expenses rose by 48.1%, from $32.8M to $48.6M. In its most recent filing year (2023), New Jersey Organ And Tissue Sharing Network Inc reported a surplus of $5.6M, with revenue exceeding expenses. The organization holds $14.1M in liabilities against $62.0M in assets (debt-to-asset ratio: 22.8%), resulting in net assets of $47.9M.

YearRevenueExpensesAssetsLiabilitiesOfficer Comp. %PDF
2023 $54.2M $48.6M $62.0M $14.1M
2022 $62.3M $56.7M $56.5M $14.9M
2021 $60.7M $56.3M $48.0M $10.5M View 990
2020 $49.3M $44.9M $44.9M $12.3M View 990
2019 $51.4M $46.2M $38.7M $10.8M View 990
2018 $41.5M $40.1M $31.0M $8.8M View 990
2017 $42.4M $40.8M $26.8M $6.1M View 990
2016 $42.3M $38.6M $27.1M $8.1M View 990
2015 $37.5M $34.1M $24.6M $9.2M View 990
2014 $31.0M $31.5M $19.4M $6.6M View 990
2013 $33.7M $31.7M $18.5M $5.3M View 990
2012 $33.0M $32.8M $16.1M $4.9M View 990
2011 $33.6M $32.8M $15.6M $3.8M View 990

Year-by-Year Financial Summary

  • 2023: Revenue of $54.2M, expenses of $48.6M, and assets of $62.0M (revenue -13.0% year-over-year).
  • 2022: Revenue of $62.3M, expenses of $56.7M, and assets of $56.5M (revenue +2.6% year-over-year).
  • 2021: Revenue of $60.7M, expenses of $56.3M, and assets of $48.0M (revenue +23.1% year-over-year).
  • 2020: Revenue of $49.3M, expenses of $44.9M, and assets of $44.9M (revenue -3.9% year-over-year).
  • 2019: Revenue of $51.4M, expenses of $46.2M, and assets of $38.7M (revenue +23.6% year-over-year).
  • 2018: Revenue of $41.5M, expenses of $40.1M, and assets of $31.0M (revenue -2.1% year-over-year).
  • 2017: Revenue of $42.4M, expenses of $40.8M, and assets of $26.8M (revenue +0.3% year-over-year).
  • 2016: Revenue of $42.3M, expenses of $38.6M, and assets of $27.1M (revenue +12.9% year-over-year).
  • 2015: Revenue of $37.5M, expenses of $34.1M, and assets of $24.6M (revenue +20.8% year-over-year).
  • 2014: Revenue of $31.0M, expenses of $31.5M, and assets of $19.4M (revenue -7.9% year-over-year).
  • 2013: Revenue of $33.7M, expenses of $31.7M, and assets of $18.5M (revenue +1.9% year-over-year).
  • 2012: Revenue of $33.0M, expenses of $32.8M, and assets of $16.1M (revenue -1.6% year-over-year).
  • 2011: Revenue of $33.6M, expenses of $32.8M, and assets of $15.6M.

View Individual Filing Years

Explore detailed financial data from each IRS 990 filing year for New Jersey Organ And Tissue Sharing Network Inc:

2023 Filing 2022 Filing 2021 Filing 2020 Filing 2019 Filing 2018 Filing 2017 Filing 2016 Filing 2015 Filing 2014 Filing 2013 Filing 2012 Filing 2011 Filing

Data Sources and Methodology

This transparency report for New Jersey Organ And Tissue Sharing Network Inc is generated by NonprofitSpending's AI analysis engine. The data is sourced from publicly available IRS 990 filings accessed through the ProPublica Nonprofit Explorer API and IRS electronic filing records. The Mission Score, spending breakdown, and other analytical insights are produced by artificial intelligence and should be used as one of multiple factors when evaluating a nonprofit organization.

IRS 990 forms are annual information returns that most tax-exempt organizations must file with the IRS. These forms provide detailed financial information including revenue, expenses, assets, liabilities, and compensation of officers. NonprofitSpending processes this data to provide accessible transparency reports for donors, researchers, and the general public.

Disclaimer

AI-generated analysis based on IRS public records. Not financial or legal advice. Verify information directly with the organization.

Other Nonprofits in New Jersey

Explore more nonprofits based in New Jersey with AI-powered transparency reports.

View all New Jersey nonprofits →

Similar Organizations (NTEE E650)

Other nonprofits classified under NTEE code E650.

View all E650 nonprofits →

Explore Related Nonprofits

Browse by State